BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 4082851)

  • 21. [Antithrombin III in 86 patients with venous thrombosis (author's transl)].
    Juillet Y; Aiach M; Fiessinger JN; Leclerc M; Housset E
    Sem Hop; 1978 Nov 8-15; 54(37-40):1126-9. PubMed ID: 217091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P; Moulonguet-Doleris L; Costa JM; Aiach M
    Thromb Haemost; 1991 Jan; 65(1):20-4. PubMed ID: 2024235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pregnancy and thrombophilia in women with congenital deficit of antithrombin III, protein C, protein S or plasminogen: analysis of 39 cases].
    Montagud M; Montserrat I; Oliver A; Adelantado JM; Mateo J; Borrell M; Fontcuberta J
    Med Clin (Barc); 1993 Feb; 100(6):201-4. PubMed ID: 8429723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin III. Key factor in extracorporeal circulation.
    Ranucci M
    Minerva Anestesiol; 2002 May; 68(5):454-7. PubMed ID: 12029263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thrombosis: antithrombin III deficiency.
    Halfman M; Berg DE
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):499-509. PubMed ID: 8217045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
    Chamontin B; Guittard J; Laroche M; Boneu B; Salvador M
    Arch Mal Coeur Vaiss; 1984 Sep; 77(9):1064-7. PubMed ID: 6435583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency.
    Nishimura Y; Takagi Y
    Ann Thorac Cardiovasc Surg; 2018 Aug; 24(4):187-192. PubMed ID: 29681597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.
    Nelson DM; Stempel LE; Brandt JT
    Obstet Gynecol; 1985 Jun; 65(6):848-53. PubMed ID: 4039808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement.
    Francis CW; Pellegrini VD; Harris CM; Marder VJ
    Am J Med; 1989 Sep; 87(3B):61S-66S. PubMed ID: 2478015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [L-asparaginase, antithrombin III deficiency and thromboses (author's transl)].
    Bordigoni P; Briquel E; Olive D
    Arch Fr Pediatr; 1981 Nov; 38(9):653-5. PubMed ID: 6949499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin deficiency in special clinical syndromes--Part II: trauma/burns.
    Penner J
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):42-7; discussion 48. PubMed ID: 8821209
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
    Gromnica-Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of synthetic chromogenic substrates for the control of antithrombosis therapy with small doses of heparin].
    Bokarew IM; Butorow WN; Gordejew PS; Kusnezow WA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):142-9. PubMed ID: 6177595
    [No Abstract]   [Full Text] [Related]  

  • 37. [Atrial Septal Defect with Hereditary Deficiency of Antithrombin III].
    Naruse H; Sakamoto Y; Kinouchi K; Inoue T; Matsumura Y; Yoshitake M; Bando K; Hashimoto K
    Kyobu Geka; 2016 Jul; 69(7):508-10. PubMed ID: 27365061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antithrombin III deficiency: when substitute, when heparin? Thrombosis ABC, 3: The role of antithrombin III].
    Stiefelhagen P
    MMW Fortschr Med; 1999 Sep; 141(37):41. PubMed ID: 10897973
    [No Abstract]   [Full Text] [Related]  

  • 40. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.